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Objective: To discuss the expression and signiﬁcance of angiostatin, vascular endo-
thelial growth factor and matrix metalloproteinase-9 in the brain tissue of diabetic rats
with ischemia reperfusion.
Methods: A total of 60 male Wistar rats were randomly divided into the normal group,
sham group, diabetic cerebral infarction group and single cerebral infarction group ac-
cording to the random number table, with 15 rats in each group. The high sucrose diet and
intraperitoneal injection of streptozotocin were performed for the modeling of diabetic
rats, while the thread-occlusion method was employed to build the model of cerebral
ischemia reperfusion. The immunohistochemical staining was performed to detect the
expression of angiostatin, vascular endothelial growth factor (VEGF) and matrix
metalloproteinase-9 (MMP-9) in the brain tissue.
Results: The expression of angiostatin after the reperfusion in the brain tissue of rats in
the single cerebral infarction group and diabetic cerebral infarction group was increased
6 h after the reperfusion, reached to the peak on 1 d and then decreased gradually. The
expression of angiostatin in the diabetic cerebral infarction group 6 h, 1 d, 3 d and 7 d
after the reperfusion was signiﬁcantly higher than that in the single cerebral infarction
group (P < 0.05). VEGF began to be increased 1 h after the reperfusion in the single
cerebral infarction group and diabetic cerebral infarction group, reached to the peak at 6 h
and then decreased gradually. The expression of VEGF in the diabetic cerebral infarction
group at each time point after the reperfusion was signiﬁcantly lower than that in the
single cerebral infarction group (P < 0.05). MMP-9 began to be increased 1 h after the
reperfusion in the single cerebral infarction group and diabetic cerebral infarction group,
reached to the peak on 1 d and then decreased gradually. The expression of MMP-9 in the
diabetic cerebral infarction group at each time point after the reperfusion was signiﬁcantly
higher than that in the single cerebral infarction group (P < 0.05).
Conclusions: The high glucose environment in which the diabetic cerebral infarction is
occurred is to induce the formation of MMP-9 at ﬁrst and then activate and increase the
expression of angiostatin. Afterwards, the expression of VEGF is inhibited, resulting in
the poor angiogenesis after cerebral infarction, which thus makes the injury of brain tissue
after cerebral infarction even worse than the non-diabetes mellitus.der the CC BY-NC-ND license (http://
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The impairment of cerebral blood supply can cause the
ischemia and hypoxia of brain tissue and then result in the ce-
rebral infarction. The focus of cerebral infarction mainly consists
of the ischemic penumbra and central necrotic area. The central
area would induce the apoptosis of brain cells because of
ischemia, while the collateral circulation in which the penumbra
exists could provide the blood for the focus and thus there would
still be a great number of alive neuronal cells [1,2]. If repairing
the metabolic function of brain after the injury as soon as
possible, the function of some neuronal cells can be recovered.
Accordingly, the building of effective collateral circulation
would be of critical signiﬁcance for reversing the injury of
neuronal cells and improving the neural function [3]. The
prognosis of patients with diabetes mellitus and cerebral
infarction is even poorer than that of patients with single
cerebral infarction. The animal experiment proved that [4] the
combined diabetes mellitus could signiﬁcantly reduce the
collateral circulation of cardiac muscular tissue and focus of
cerebral infarction and thus aggravated the tissue injury after
the cerebral ischemia. There have been many researches that
reported the diabetes mellitus could aggravate the injury of
cerebral infarction tissue, but no deﬁnite conclusion could be
drawn. Therefore, in this study, by building the model of
diabetic rats with ischemia reperfusion injury and observing
the expression of angiostatin, vascular endothelial growth
factor (VEGF) and matrix metalloproteinase-9 (MMP-9) in the
focus tissues, it was to discuss the possible pathophysiological
mechanism of diabetic rats with ischemia reperfusion injury, in
order to provide the new thought for the further clinical treat-
ment and pharmaceutical development. The ﬁndings were
summarized as follows.
2. Materials and methods
2.1. Materials
A total of 60 male Wistar rats were provided by Laboratory
Animal Center of School of Medicine, Shandong University,
with the weight of (180–230) g and average weight of
(206.3 ± 13.8) g; 60 rats were randomly divided into 4 groups
according to the random number table: normal group, sham
group, diabetic cerebral infarction group and single cerebral
infarction group, with 15 rats in each group. Rats in each group
were divided into 5 subgroups according to 1 h, 6 h, 1 d, 3 d and
7 d of ischemia reperfusion, with 3 rats in each subgroup. The
feeding conditions were as follows: the temperature of feeding
room was maintained at (20–22) C, the room humidity was
50% and rats were given the diet and water freely, with 12 h of
lighting and 12 h of darkness by turns. The experiment was
performed 1 week after the feeding. The experimental protocol,
operation and animal ethics of this study were reviewed and
approved by School of Medicine, Shandong University.
2.2. Methods
2.2.1. Modeling of diabetic rats
Rats in the diabetic cerebral infarction group were given the
high sucrose diet for 2 months and then the intraperitoneal in-
jection of streptozotocin (STZ, which was purchased fromSigma). The blood glucose and weight were measured 1 month
and 2 months after the injection. The modeling standards were as
follows: the weight of rats was (290–360) g and the blood
glucose level was (16.7–25.6) mmol/L (not fasting).
2.2.2. Modeling of cerebral ischemia reperfusion
The model of cerebral ischemia reperfusion was built using
Zea-Longer thread-occlusion method [5] for rats in the diabetic
cerebral infarction group and single cerebral infarction group:
rats were placed on the operating table at 25 C in a supine
position. After being ﬁxed, they were given the intraperitoneal
injection of 35 mg/100 g 10% chloral hydrate. An incision
was done in the middle of neck to separate the external
carotid artery, internal carotid artery and common carotid
artery. The proximal part of external carotid artery and internal
carotid artery were ligated. The eye scissors were used to cut
an incision at the distal part of common carotid artery (about
5 mm to the bifurcation) and the nylon thread was inserted,
with the depth of about 25 mm. The thread occlusion was
then ﬁxed. The skin and muscle were sutured and disinfected
layer by layer. After 1.5 h of thread occlusion, the thread was
pulled out to realize the ischemia reperfusion. The rectal
temperature of rats was maintained at (36.5–37.5) C during
the operation and the right middle cerebral artery was chosen
as the embolization artery. The nylon thread was inserted in
rats of sham group with the depth of about 16 mm and the left
operations were the same as above. The modeling standard of
ischemia reperfusion was: when the rats were awakened from
the anesthesia, the Longa score [6] was employed to evaluate
the neural function of rats, where a score of 0 indicated no
neurologic deﬁcit, a score of 1 failure to extend left forepaw
fully, a score of 2 circling of forepaws when walking, a score
of 3 falling to the left when walking ahead and 4 no
spontaneous walk and loss of consciousness. The score of 1–3
indicated the successful modeling.
2.2.3. Sampling
The detection was performed at 5 time points of 1 h, 6 h, 1 d,
3 d and 7 d after the ischemia reperfusion. The head of rats was
broken and the brain was collected. After being placed in the
liquid nitrogen, they were ﬁxed and dehydrated. Afterwards,
they were treated with the common parafﬁn embedding, with the
slice thickness of 4 mm. The immunohistochemical staining was
employed to detect the expression of angiostatin, VEGF and
MMP-9 in the brain tissue. The slices were deparafﬁnized using
the regular method. After adding 3% H2O2, it was placed in the
microwave for 10 min to repair the antigen. After 15 min of
adding the goat serum blocking solution and 3 h of adding the
primary antibody, it was washed with 0.1 mol/LPBS for 3 times,
with 5 min each time. Afterwards, the secondary antibody was
added for 1.5 h and it was washed with 0.1 mol/LPBS for 3
times, with 5 min each time. After the DAB staining, it was
restained with hematoxylin. The primary antibody was replaced
by PBS in the negative control, with the remained steps same as
above. The antibodies of angiostatin, VEGF and MMP-9 were
all purchased from Sigma.
2.3. Outcome evaluation
The angiostatin and VEGF with positive staining were
mainly in the cell membrane and cytoplasm, while MMP-9 was
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yellow or yellowish brown. Ten ﬁelds were randomly selected
for the observation under the microscope at ×400. The number
of positive cells in each ﬁeld was counted and the average of 10
ﬁelds was calculated.
2.4. Statistical analysis
The data was treated with SPSS19.0. The measurement data
was expressed by mean ± sd. The two-way repeated-measures
ANOVA was employed for the comparison among different
time points, while SNK-q test for the comparison between
groups. P < 0.05 indicated the signiﬁcant difference.
3. Results
3.1. Results of focal staining after cerebral infarction
The sections of brain tissue of rats in the diabetic cerebral
infarction group and single cerebral infarction group appeared to
be pale in the infarction area. The number of neuronal cells was
signiﬁcantly reduced in the central area of infarction, with the
understain in the cytoplasm. The area around the infarction had
the cellular degeneration, swelling and understained cytoplasm;
some small blood vessels had the obvious dilatation and
congestion, with the inﬂammatory inﬁltration around. The de-
gree of cerebral infarction for rats in the diabetic cerebral
infarction group was even worse than that in the single cerebral
infarction group.
3.2. Evaluation results of neural function for rats in
each group
Rats in the diabetic cerebral infarction group and single
cerebral infarction group had the Homer syndromes such as
the droopy right eyeball and blepharophimosis when they
awakened after the anesthesia, with the bending of left fore-
limb, falling to the left or circling to the left when walking; theTable 1
Expression of angiostatin in brain tissue of rats in each group (Mean ± SD).
Group 1 h 6 h
Normal group 0.08 ± 0.02 0.07 ± 0.02
Sham group 0.91 ± 0.16 0.93 ± 0.17
Single cerebral infarction group 0.94 ± 0.17 1.02 ± 0.18
Diabetic cerebral infarction group 0.96 ± 0.19 1.14 ± 0.21
Note: a compared with the normal group, P < 0.05; b compared with the sh
cerebral infarction group at the same time point, P < 0.05.
Table 2
Expression of VEGF in brain tissue of rats in each group (Mean ± SD).
Group 1 h 6 h
Normal group 0.21 ± 0.07 0.18 ± 0.0
Sham group 1.04 ± 0.09a 0.98 ± 0.0
Single cerebral infarction group 3.24 ± 0.13ab 15.79 ± 1.0
Diabetic cerebral infarction group 3.34 ± 0.15abc 11.06 ± 0.6
Note: a compared with the normal group, P < 0.05; b compared with the sh
cerebral infarction group at the same time point, P < 0.05.score of neural function was 1–3; rats in the sham group also
had the Homer syndromes such as the droopy right eyeball and
blepharophimosis, but no other defected neural function; rats
in the normal group had the normal neural function and
behavior.
3.3. Expression of angiostatin in brain tissue of rats in
each group
The expression of angiostatin in the brain tissue of rats in the
normal group was limited in the nervous plexus; while the
expression of angiostatin in the sham group was signiﬁcantly
higher than that in the normal group (F = 14.035, P < 0.05). The
expression of angiostatin after the reperfusion in the brain tissue
of rats in the single cerebral infarction group and diabetic ce-
rebral infarction group was increased 6 h after the reperfusion,
reached to the peak on 1 d and then decreased gradually
(F = 7.558, P < 0.05). The expression of angiostatin in the
diabetic cerebral infarction group 6 h, 1 d, 3 d and 7 d after the
reperfusion was signiﬁcantly higher than that in the single ce-
rebral infarction group (F = 4.951, P < 0.05), as shown in
Table 1.
3.4. Expression of VEGF in brain tissue of rats in each
group
The expression of VEGF for rats in the normal group and
sham group was limited in the in the brain tissue, which was
mainly in the nervous plexus; while the expression of angiostatin
in the sham group was signiﬁcantly higher than that in the
normal group (F = 29.406, P < 0.05); VEGF began to be
increased 1 h after the reperfusion in the single cerebral
infarction group and diabetic cerebral infarction group, reached
to the peak at 6 h and then decreased gradually (F = 14.338,
P = 0.000). The expression of VEGF in the diabetic cerebral
infarction group at each time point after the reperfusion was
signiﬁcantly lower than that in the single cerebral infarction
group (F = 8.095, P < 0.05), as shown in Table 2.1 d 3 d 7 d
0.08 ± 0.01 0.09 ± 0.02 0.08 ± 0.01
a 0.92 ± 0.21a 0.94 ± 0.19a 0.95 ± 0.20a
ab 1.27 ± 0.19ab 1.12 ± 0.16ab 1.03 ± 0.19ab
abc 1.38 ± 0.21abc 1.18 ± 0.18abc 1.17 ± 0.09abc
am group at the same time point, P < 0.05; c compared with the single
1 d 3 d 7 d
5 0.19 ± 0.07 0.19 ± 0.06 0.18 ± 0.03
8a 1.03 ± 0.05a 1.03 ± 0.07a 0.99 ± 0.06a
5ab 14.79 ± 0.79ab 9.04 ± 0.21ab 6.01 ± 0.17ab
8abc 13.04 ± 0.73abc 7.31 ± 0.28abc 4.73 ± 0.15abc
am group at the same time point, P < 0.05; c compared with the single
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group
The expression MMP-9 was only found in the hippocampus,
vascular endothelium and nervous plexus of brain tissue for rats
in the normal group and sham group, with the scattered distri-
bution and limited positive expression; where the expression of
MMP-9 in the sham group was signiﬁcantly higher than that in
the normal group (F = 14.035, P < 0.05); MMP-9 began to
increase 1 h after the reperfusion in the single cerebral infarction
group and diabetic cerebral infarction group, reached to the peak
on 1 d and then decreased gradually (F = 7.558, P = 0.000). The
expression of MMP-9 in the diabetic cerebral infarction group at
each time point after the reperfusion was signiﬁcantly higher
than that in the single cerebral infarction group (F = 4.951,
P < 0.05), as shown in Table 3.Table 3
Expression of MMP-9 in brain tissue of rats in each group (Mean ± SD).
Group 1 h 6 h 1 d 3 d 7 d
Normal group 0.08 ± 0.03 0.09 ± 0.02 0.07 ± 0.01 0.07 ± 0.02 0.09 ± 0.03
Sham group 0.73 ± 0.12a 0.77 ± 0.15a 0.69 ± 0.11a 0.73 ± 0.11a 0.74 ± 0.13a
Single cerebral infarction group 2.28 ± 0.08ab 8.10 ± 0.49ab 36.69 ± 4.95ab 20.47 ± 1.59ab 13.29 ± 1.32ab
Diabetic cerebral infarction group 2.74 ± 0.10abc 12.04 ± 0.74abc 46.79 ± 5.71abc 28.39 ± 2.30abc 17.30 ± 1.78abc
Note: a compared with the normal group, P < 0.05; b compared with the sham group at the same time point, P < 0.05; c compared with the single
cerebral infarction group at the same time point, P < 0.05.4. Discussion
The cerebral infarction is mainly caused by the necrotic
lesion because of the ischemia and hypoxia that is induced by
the impairment of cerebral blood supply. For the acute cerebral
infarction, its focus mainly consists of the ischemic penumbra
and central necrotic area, where the nerve cells has the apoptosis
in the central necrotic area and the collateral circulation in which
the penumbra exists can provide the blood for the focus and thus
there will still be a great number of alive neuronal cells. If the
function of blood ﬂow can be recovered, the part of damaged
neuronal cells will be reversed, which is also the protection
mechanism of ischemia reperfusion. Yang et al. [7] ligated the
common carotid artery of rats and the results showed that the
vessel density around the cerebral infarction was signiﬁcantly
increased after the ischemia. The further study indicated the
formation of collateral circulation and new vessels. Such
self-protection mechanism might be helpful for the recovery
of neural function [8,9]. The angiogenesis of brain tissue is
a complicated process. Firstly, the basement membrane began
to be decomposed to induce the division of endothelial cells,
which would be proliferated into the cytokine. Afterwards,
the vascular cavity would be formed and then the new
vessels [10,11]. Many regulatory factors are involved in the
process of angiogenesis, such as the angiostatin, matrix
metalloproteinase-9 and vascular endothelial growth factor.
Where, the vascular endothelial growth factor belongs to the
positive regulatory factor and the increased expression will be
helpful for the angiogenesis; while the increased expression of
negative regulatory factor such as the angiostatin will be adverse
to the angiogenesis.
Kim et al. [12] performed the continuous observation on rat
model of cerebral infarction. The results showed that theexpression of MMP-9 was continuously increased in the
infarction focus within 24 h of infarction, which indicated that
the extracellular matrix began to be decomposed to induce the
angiogenesis and then provide the blood for the ischemic pen-
umbra to recover part of injured nerve cells. However, the
continuously high expression of MMP-9 would inhibit the
angiogenesis. The cause of such situation has not been clear yet.
But some evidence [13] indicated that the high expression of
MMP-9 would inhibit the level of VEGF. Generally, MMP-9
had the negative regulation on VEGF. According to Soejima
et al. [14], the high glucose environment could activate the
activity of MMPs in the artery and stimulate the expression
and activation of MMPs to cause the blocked collateral
circulation of coronary artery and aggravate the injury of brain
tissue in the infarction focus. The results of this study also
indicated that the expression of MMP-9 in the single cerebralinfarction group and diabetic cerebral infarction group was
signiﬁcantly higher than that in the normal group and sham
group, but the expression of MMP-9 in the brain tissue after
reperfusion in the diabetic cerebral infarction group was
signiﬁcantly higher than that in the single cerebral infarction
group, which further proved the above conclusion. Some clues
regarding the relationship between MMP-9 and VEGF might be
found from the data: the expression of VEGF and MMP-9 began
to be increased 1 h after the reperfusion in the single cerebral
infarction group and diabetic cerebral infarction group, where
the expression of VEGF reached to the peak at 6 h and the
expression of MMP-9 to the peak on 1 d. It indicated that the
ischemia stimulation would all induce the increased expression
of VEGF and MMP-9. As the time of ischemia prolonged, the
changes in VEGF and MMP-9 began to be diversiﬁed. The
continuously high expression of MMP-9 would have the inhi-
bition against VEGF and thus block the angiogenesis. It meant
that 6 h after the ischemia might be the best time for the treat-
ment of cerebral infarction. At this point, the collateral circula-
tion of ischemic penumbra reached to the peak. Afterwards, the
angiogenesis was blocked and the collateral circulation of
ischemic penumbra was inhibited [15].
There have been limited researches concerning the relation-
ship between the angiostatin and cerebral infarction. The foreign
researches [16,17] reported that the degradation products of
MMPs, MMP-7 and MMP-9, could dissolve the plasminogen
and then activate the angiostatin. It also proved that the
angiostatin could inhibit the formation of VEGF and then block
the angiogenesis. Takahashi et al. [18] reported that the
angiostatin could induce the apoptosis of endothelial cells and
then conﬁned the angiogenesis in the stage of lumen
formation. Besides, the angiostatin could also inhibit ATP
synthase and cause the acidosis of cells and then induce the
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P44 MAP kinase, the VEGF signal transduction pathway, and
then block the formation process of VEGF. According to the
results of this study, the expression of angiostatin after the
reperfusion in the brain tissue of rats in the single cerebral
infarction group and diabetic cerebral infarction group was
increased 6 h after the reperfusion, reached to the peak on 1 d
and then decreased gradually. The time of its increase was
later than MMP-9, while the peak and decrease time of its
expression were the same as MMP-9. Accordingly, it could be
presumed that the expression of MMP-9 was increased gradually
and it acted on the substrate of plasminogen to activate the
angiostatin, which would inhibit the angiogenesis together.
In conclusion, the high glucose environment in which the
diabetic cerebral infarction existed would induce the formation
of MMP-9 at ﬁrst, further activate the expression of angiostatin,
inhibit the expression of VEGF and then cause the poor
angiogenesis after the cerebral infarction and make the tissue
injury after cerebral infarction more serious than the diabetes
mellitus.
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